Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence.

Eny KM, Lutgers HL, Maynard J, Klein BE, Lee KE, Atzmon G, Monnier VM, van Vliet-Ostaptchouk JV, Graaff R, van der Harst P, Snieder H, van der Klauw MM, Sell DR, Hosseini SM, Cleary PA, Braffett BH, Orchard TJ, Lyons TJ, Howard K, Klein R, Crandall JP, Barzilai N, Milman S, Ben-Avraham D; LifeLines Cohort Study Group; DCCT/EDIC Research Group, Wolffenbuttel BH, Paterson AD.

Diabetologia. 2014 Aug;57(8):1623-34. doi: 10.1007/s00125-014-3286-9. Epub 2014 Jun 17.

2.

A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.

García-Closas M, Hein DW, Silverman D, Malats N, Yeager M, Jacobs K, Doll MA, Figueroa JD, Baris D, Schwenn M, Kogevinas M, Johnson A, Chatterjee N, Moore LE, Moeller T, Real FX, Chanock S, Rothman N.

Pharmacogenet Genomics. 2011 Apr;21(4):231-6. doi: 10.1097/FPC.0b013e32833e1b54.

3.

Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.

Hein DW, Doll MA.

Pharmacogenomics. 2012 Jan;13(1):31-41. doi: 10.2217/pgs.11.122. Epub 2011 Nov 17.

4.

tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity.

Chamorro JG, Castagnino JP, Musella RM, Nogueras M, Frías A, Visca M, Aidar O, Costa L, de Larrañaga GF.

Pharmacogenet Genomics. 2016 Jul;26(7):357-61. doi: 10.1097/FPC.0000000000000224.

PMID:
27104815
5.

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Torà M, Fernández F, Real FX, Rothman N.

Lancet. 2005 Aug 20-26;366(9486):649-59.

6.
7.

N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus.

Irshaid YM, Abujbara MA, Ajlouni KM, El-Khateeb M, Jarrar YB.

Int J Clin Pharmacol Ther. 2013 Jul;51(7):593-9. doi: 10.5414/CP201883.

PMID:
23587153
8.

The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity.

Ho HT, Wang TH, Hsiong CH, Perng WC, Wang NC, Huang TY, Jong YJ, Lu PL, Hu OY.

Pharmacogenet Genomics. 2013 Apr;23(4):200-7. doi: 10.1097/FPC.0b013e32835e95e1.

PMID:
23407048
9.

Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.

Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, Vainio H.

J Natl Cancer Inst. 1996 Dec 18;88(24):1853-6.

PMID:
8961976
10.

N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.

Hamasaki T, Inatomi H, Katoh T, Aono H, Ikuyama T, Muratani T, Matsumoto T.

Int J Urol. 2003 Mar;10(3):167-73.

11.

Single nucleotide polymorphism coverage and inference of N-acetyltransferase-2 acetylator phenotypes in wordwide population groups.

Suarez-Kurtz G, Fuchshuber-Moraes M, Struchiner CJ, Parra EJ.

Pharmacogenet Genomics. 2016 Aug;26(8):363-9. doi: 10.1097/FPC.0000000000000225.

PMID:
27136043
12.
13.

rs1495741 as a tag single nucleotide polymorphism of N-acetyltransferase 2 acetylator phenotype associates bladder cancer risk and interacts with smoking: A systematic review and meta-analysis.

Ma C, Gu L, Yang M, Zhang Z, Zeng S, Song R, Xu C, Sun Y.

Medicine (Baltimore). 2016 Aug;95(31):e4417. doi: 10.1097/MD.0000000000004417. Review.

14.

Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.

Doll MA, Zang Y, Moeller T, Hein DW.

J Pharmacol Exp Ther. 2010 Aug;334(2):540-4. doi: 10.1124/jpet.110.168567. Epub 2010 Apr 29.

16.

Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.

Taja-Chayeb L, González-Fierro A, Miguez-Muñoz C, Trejo-Becerril C, Cruz-Hernandez Ede L, Cantu D, Agundez JA, Vidal-Millan S, Gutierrez O, Dueñas-González A.

Pharmacogenet Genomics. 2011 Dec;21(12):894-901. doi: 10.1097/FPC.0b013e32834bec2b.

PMID:
21946899
17.

N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.

Deitz AC, Zheng W, Leff MA, Gross M, Wen WQ, Doll MA, Xiao GH, Folsom AR, Hein DW.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):905-10.

18.

N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.

Borlak J, Reamon-Buettner SM.

BMC Med Genet. 2006 Jul 9;7:58.

19.

Impact of population diversity on the prediction of 7-SNP NAT2 phenotypes using the tagSNP rs1495741 or paired SNPs.

Suarez-Kurtz G, Sortica VA, Vargens DD, Bruxel EM, Petzl-Erler ML, Tsuneto LT, Hutz MH.

Pharmacogenet Genomics. 2012 Apr;22(4):305-9. doi: 10.1097/FPC.0b013e3283519c7c. Erratum in: Pharmacogenet Genomics. 2012 May;22(5):397. Petz-Erler, Maria-Luiza [corrected to Petzl-Erler, Maria-Luiza].

PMID:
22336957
20.

[The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].

An HR, Wu XQ, Wang ZY, Liang Y, Zhang JX.

Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Jan;45(1):36-40. Chinese.

PMID:
21418817

Supplemental Content

Support Center